Purple Biotech Ltd. SEC filings PPBT

Purple Biotech Ltd. has 576 filings in SEC EDGAR's recent list, going back to Aug 18, 2014. Its latest annual report, Form 20-F, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 5, 2026. The company's fiscal year ends on December 31.

Purple Biotech Ltd. SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Oct 5, 2026 Oct 5, 2026
6-K Current report (foreign issuer) Sep 9, 2026 Sep 9, 2026
6-K Current report (foreign issuer) Sep 2, 2026 Sep 2, 2026
6-K Current report (foreign issuer) Aug 10, 2026 Aug 10, 2026
6-K Current report (foreign issuer) Aug 7, 2026 Aug 7, 2026
6-K Current report (foreign issuer) Jul 29, 2026 Jul 29, 2026
6-K Current report (foreign issuer) Jun 23, 2026 Jun 23, 2026
6-K Current report (foreign issuer) Jun 11, 2026 Jun 11, 2026
F-3 Shelf registration (foreign issuer) May 20, 2026 —
6-K Current report (foreign issuer) May 15, 2026 May 15, 2026
6-K Current report (foreign issuer) Apr 27, 2026 Apr 27, 2026
6-K Current report (foreign issuer) Apr 23, 2026 Apr 23, 2026
6-K Current report (foreign issuer) Mar 25, 2026 Mar 25, 2026
6-K Current report (foreign issuer) Mar 19, 2026 Mar 18, 2026
20-F Annual report (foreign issuer) Mar 19, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Mar 17, 2026 Mar 17, 2026
6-K Current report (foreign issuer) Mar 13, 2026 Mar 13, 2026
6-K Current report (foreign issuer) Feb 25, 2026 Feb 25, 2026
6-K Current report (foreign issuer) Jan 13, 2026 Jan 12, 2026
6-K Current report (foreign issuer) Jan 7, 2026 Jan 7, 2026
6-K Current report (foreign issuer) Dec 16, 2025 Dec 16, 2025
6-K Current report (foreign issuer) Dec 11, 2025 Dec 11, 2025
6-K Current report (foreign issuer) Nov 19, 2025 Nov 19, 2025
6-K Current report (foreign issuer) Nov 14, 2025 Nov 14, 2025
6-K Current report (foreign issuer) Oct 29, 2025 Oct 29, 2025
6-K Current report (foreign issuer) Oct 28, 2025 Oct 28, 2025
6-K Current report (foreign issuer) Oct 20, 2025 Oct 20, 2025
6-K Current report (foreign issuer) Sep 19, 2025 Sep 19, 2025
424B5 Prospectus supplement Sep 19, 2025 —
6-K Current report (foreign issuer) Sep 16, 2025 Sep 15, 2025
6-K Current report (foreign issuer) Sep 10, 2025 Sep 10, 2025
6-K Current report (foreign issuer) Sep 5, 2025 Sep 5, 2025
424B4 Prospectus Sep 5, 2025 —
EFFECT Filing Sep 4, 2025 —
6-K Current report (foreign issuer) Sep 4, 2025 Sep 4, 2025
6-K Current report (foreign issuer) Sep 3, 2025 Sep 3, 2025
CORRESP Letter to the SEC Aug 29, 2025 —
CORRESP Letter to the SEC Aug 29, 2025 —
F-1 Registration statement (foreign issuer) Aug 29, 2025 —
6-K Current report (foreign issuer) Aug 6, 2025 Aug 6, 2025
6-K Current report (foreign issuer) Jul 23, 2025 Jul 23, 2025
UPLOAD Letter from the SEC Jul 15, 2025 —
6-K Current report (foreign issuer) Jul 10, 2025 Jul 10, 2025
DRS Filing Jul 10, 2025 —
6-K Current report (foreign issuer) Jun 23, 2025 Jun 23, 2025
6-K Current report (foreign issuer) Jun 17, 2025 Jun 17, 2025
6-K Current report (foreign issuer) May 21, 2025 May 21, 2025
6-K Current report (foreign issuer) May 12, 2025 May 12, 2025
6-K Current report (foreign issuer) May 6, 2025 May 6, 2025
6-K Current report (foreign issuer) Apr 30, 2025 Apr 30, 2025
6-K Current report (foreign issuer) Apr 28, 2025 Apr 28, 2025
6-K Current report (foreign issuer) Apr 22, 2025 Apr 22, 2025
6-K Current report (foreign issuer) Apr 16, 2025 Apr 16, 2025
6-K Current report (foreign issuer) Apr 15, 2025 Apr 15, 2025
6-K Current report (foreign issuer) Apr 1, 2025 Apr 1, 2025
6-K Current report (foreign issuer) Mar 28, 2025 Mar 28, 2025
6-K Current report (foreign issuer) Mar 18, 2025 Mar 18, 2025
20-F Annual report (foreign issuer) Mar 10, 2025 Dec 31, 2024
6-K/A Amendment no. 1 to form 6-k Mar 10, 2025 Mar 10, 2025
6-K Current report (foreign issuer) Mar 10, 2025 Mar 10, 2025
6-K Current report (foreign issuer) Mar 5, 2025 Mar 5, 2025
6-K Current report (foreign issuer) Feb 28, 2025 Feb 28, 2025
6-K Current report (foreign issuer) Feb 18, 2025 Feb 18, 2025
6-K Current report (foreign issuer) Feb 3, 2025 Feb 3, 2025
6-K Current report (foreign issuer) Jan 6, 2025 Jan 6, 2025
424B5 Prospectus supplement Jan 6, 2025 —
6-K Current report (foreign issuer) Dec 6, 2024 Dec 6, 2024
6-K Current report (foreign issuer) Dec 5, 2024 Dec 5, 2024
6-K Current report (foreign issuer) Dec 4, 2024 Dec 4, 2024
424B5 Prospectus supplement Dec 4, 2024 —
6-K Current report (foreign issuer) Dec 3, 2024 Dec 3, 2024
6-K Current report (foreign issuer) Dec 2, 2024 Dec 2, 2024
6-K Current report (foreign issuer) Nov 15, 2024 Nov 15, 2024
6-K Current report (foreign issuer) Nov 4, 2024 Nov 4, 2024
6-K Current report (foreign issuer) Oct 25, 2024 Oct 25, 2024
6-K Current report (foreign issuer) Oct 10, 2024 Oct 10, 2024
6-K Current report (foreign issuer) Oct 9, 2024 Oct 9, 2024
6-K Current report (foreign issuer) Oct 2, 2024 Oct 2, 2024
6-K Current report (foreign issuer) Sep 18, 2024 Sep 18, 2024
6-K Current report (foreign issuer) Sep 11, 2024 Sep 11, 2024
6-K Current report (foreign issuer) Aug 19, 2024 Aug 19, 2024
6-K Current report (foreign issuer) Aug 16, 2024 Aug 16, 2024
6-K Current report (foreign issuer) Aug 8, 2024 Aug 8, 2024
6-K Current report (foreign issuer) Aug 5, 2024 Aug 5, 2024
424B3 Prospectus Jul 31, 2024 —
EFFECT Filing Jul 30, 2024 —
CORRESP Letter to the SEC Jul 26, 2024 —
UPLOAD Letter from the SEC Jul 26, 2024 —
6-K Current report (foreign issuer) Jul 25, 2024 Jul 25, 2024
F-1 Registration statement (foreign issuer) Jul 22, 2024 —
6-K Current report (foreign issuer) Jul 19, 2024 Jul 19, 2024
D Filing Jul 15, 2024 —
424B3 Prospectus Jul 2, 2024 —
6-K Current report (foreign issuer) Jul 2, 2024 Jul 2, 2024
6-K Current report (foreign issuer) Jul 2, 2024 Jul 2, 2024
6-K Current report (foreign issuer) Jul 1, 2024 Jul 1, 2024
6-K Current report (foreign issuer) Jun 27, 2024 Jun 27, 2024
6-K Current report (foreign issuer) Jun 26, 2024 Jun 26, 2024
6-K Current report (foreign issuer) Jun 20, 2024 Jun 20, 2024
6-K Current report (foreign issuer) Jun 4, 2024 Jun 4, 2024
6-K Current report (foreign issuer) Jun 3, 2024 Jun 3, 2024
6-K Current report (foreign issuer) May 21, 2024 May 21, 2024
6-K Current report (foreign issuer) May 2, 2024 May 2, 2024
6-K Current report (foreign issuer) Apr 25, 2024 Apr 25, 2024
EFFECT Filing Apr 2, 2024 —
POS AM Post-effective amendment no. 1 to form f-1 Mar 28, 2024 —
6-K Current report (foreign issuer) Mar 28, 2024 Mar 28, 2024
6-K Current report (foreign issuer) Mar 14, 2024 Mar 14, 2024
6-K Current report (foreign issuer) Mar 6, 2024 Mar 6, 2024
20-F Annual report (foreign issuer) Mar 5, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Mar 5, 2024 Mar 5, 2024
6-K Current report (foreign issuer) Feb 27, 2024 Feb 27, 2024
6-K Current report (foreign issuer) Feb 13, 2024 Feb 13, 2024
6-K Current report (foreign issuer) Feb 1, 2024 Feb 1, 2024
6-K Current report (foreign issuer) Jan 26, 2024 Jan 26, 2024
6-K Current report (foreign issuer) Dec 20, 2023 Dec 20, 2023
6-K Current report (foreign issuer) Dec 14, 2023 Dec 14, 2023
6-K Current report (foreign issuer) Nov 21, 2023 Nov 21, 2023
6-K Current report (foreign issuer) Nov 21, 2023 Nov 21, 2023
EFFECT Filing Nov 14, 2023 —
424B3 Prospectus Nov 14, 2023 —
CORRESP Letter to the SEC Nov 13, 2023 —
F-1/A Amendment no. 1 to form f-1 Nov 13, 2023 —
6-K Current report (foreign issuer) Nov 2, 2023 Nov 2, 2023
D Filing Oct 31, 2023 —
F-1 Registration statement (foreign issuer) Oct 30, 2023 —
424B3 Prospectus Oct 19, 2023 —
6-K Current report (foreign issuer) Oct 19, 2023 Oct 19, 2023
6-K Current report (foreign issuer) Oct 19, 2023 Oct 19, 2023
424B5 Prospectus supplement Oct 19, 2023 —
6-K Current report (foreign issuer) Oct 17, 2023 Oct 17, 2023
424B5 Prospectus supplement Oct 17, 2023 —
6-K Current report (foreign issuer) Oct 13, 2023 Oct 13, 2023
6-K Current report (foreign issuer) Oct 6, 2023 Oct 6, 2023
6-K Current report (foreign issuer) Oct 3, 2023 Oct 3, 2023
6-K Current report (foreign issuer) Sep 21, 2023 Sep 21, 2023
6-K Current report (foreign issuer) Sep 13, 2023 Sep 13, 2023
6-K Current report (foreign issuer) Aug 22, 2023 Aug 22, 2023
6-K Current report (foreign issuer) Jul 11, 2023 Jul 11, 2023
6-K/A Amendment no. 1 to form 6-k Jun 20, 2023 Jun 15, 2023
6-K Current report (foreign issuer) Jun 15, 2023 Jun 15, 2023
EFFECT Filing May 22, 2023 —
6-K Current report (foreign issuer) May 22, 2023 May 22, 2023
CORRESP Letter to the SEC May 18, 2023 —
F-3/A Amendment no. 1 to form f-3 May 17, 2023 —
6-K Current report (foreign issuer) May 16, 2023 May 16, 2023
6-K Current report (foreign issuer) May 1, 2023 May 1, 2023
6-K Current report (foreign issuer) Apr 25, 2023 Apr 25, 2023
6-K Current report (foreign issuer) Apr 19, 2023 Apr 19, 2023
EFFECT Filing Apr 5, 2023 —
424B3 Prospectus Apr 5, 2023 —
CORRESP Letter to the SEC Apr 3, 2023 —
424B3 Prospectus Apr 3, 2023 —
UPLOAD Letter from the SEC Mar 30, 2023 —
6-K Current report (foreign issuer) Mar 24, 2023 Mar 24, 2023
F-3 Shelf registration (foreign issuer) Mar 23, 2023 —
6-K Current report (foreign issuer) Mar 16, 2023 Mar 16, 2023
20-F Annual report (foreign issuer) Mar 3, 2023 Dec 31, 2022
6-K Current report (foreign issuer) Feb 14, 2023 Feb 14, 2023
6-K Current report (foreign issuer) Feb 8, 2023 Feb 8, 2023
6-K Current report (foreign issuer) Feb 3, 2023 Feb 3, 2023
6-K Current report (foreign issuer) Feb 2, 2023 Feb 2, 2023
6-K Current report (foreign issuer) Jan 6, 2023 Jan 6, 2023
6-K Current report (foreign issuer) Jan 3, 2023 Jan 3, 2023
UPLOAD Letter from the SEC Dec 12, 2022 —
F-3 Shelf registration (foreign issuer) Dec 8, 2022 —
6-K Current report (foreign issuer) Nov 15, 2022 Nov 15, 2022
6-K Current report (foreign issuer) Nov 9, 2022 Nov 9, 2022
6-K Current report (foreign issuer) Nov 8, 2022 Nov 8, 2022
6-K Current report (foreign issuer) Nov 2, 2022 Nov 2, 2022
6-K Current report (foreign issuer) Aug 25, 2022 Aug 25, 2022
6-K Current report (foreign issuer) Aug 4, 2022 Aug 4, 2022
6-K Current report (foreign issuer) Jul 18, 2022 Jul 18, 2022
6-K Current report (foreign issuer) Jul 14, 2022 Jul 14, 2022
6-K Current report (foreign issuer) Jun 6, 2022 Jun 6, 2022
6-K Current report (foreign issuer) May 27, 2022 May 27, 2022
6-K Current report (foreign issuer) May 18, 2022 May 18, 2022
6-K Current report (foreign issuer) May 12, 2022 May 12, 2022
6-K Current report (foreign issuer) May 2, 2022 May 2, 2022
6-K/A Amendment no. 1 to form 6-k Apr 11, 2022 Apr 11, 2022
6-K Current report (foreign issuer) Apr 11, 2022 Apr 11, 2022
S-8 Employee stock plan registration Apr 4, 2022 —
424B5 Prospectus supplement Mar 23, 2022 —
20-F Annual report (foreign issuer) Mar 9, 2022 Dec 31, 2021
6-K Current report (foreign issuer) Feb 9, 2022 Feb 9, 2022
6-K Current report (foreign issuer) Feb 4, 2022 Feb 3, 2022
6-K Current report (foreign issuer) Jan 6, 2022 Jan 6, 2022
6-K Current report (foreign issuer) Dec 29, 2021 Dec 29, 2021
6-K Current report (foreign issuer) Dec 22, 2021 Dec 22, 2021
6-K Current report (foreign issuer) Dec 9, 2021 Dec 9, 2021
6-K Current report (foreign issuer) Dec 6, 2021 Dec 6, 2021
6-K Current report (foreign issuer) Nov 16, 2021 Nov 16, 2021
6-K Current report (foreign issuer) Nov 10, 2021 Nov 10, 2021
6-K/A Amendment no. 1 to form 6-k Nov 9, 2021 Nov 9, 2021
6-K Current report (foreign issuer) Nov 4, 2021 Nov 4, 2021
6-K Current report (foreign issuer) Oct 26, 2021 Oct 26, 2021
6-K Current report (foreign issuer) Oct 22, 2021 Oct 22, 2021
6-K Current report (foreign issuer) Oct 14, 2021 Oct 14, 2021
6-K Current report (foreign issuer) Oct 8, 2021 Oct 8, 2021
6-K Current report (foreign issuer) Sep 13, 2021 Sep 13, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PPBT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Rehovot, Israel
SEC filer status
Non-accelerated filer
SEC CIK
1614744
Former names
Kitov Pharma Ltd. (until Dec 10, 2020); Kitov Pharmaceuticals Holdings Ltd. (until Dec 21, 2017)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.